The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Use of glyburide for the treatment of gestational diabetes: the San Antonio experience
Abstract
OBJECTIVES: Equivalent efficacy of glyburide and insulin for treatment of gestational diabetes (GDM) was demonstrated in a recent randomized trial. We describe our experience with glyburide in practice, and suggest factors that predict failure of glyburide treatment. METHODS: Women with GDM treated with glyburide were studied. They were divided into two groups: those who achieved adequate glycemic control with glyburide, and those who did not. The groups were compared in terms of baseline characteristics, including diabetes risk factors and glucose testing values. Receiver operating characteristics (ROC) curves were generated to identify thresholds for fasting plasma glucose and body mass index (BMI) that would predict glyburide failure. RESULTS: Seventy-five women were analyzed: 63 (84%) were successfully treated with glyburide, and 12 (16%) were not. Baseline characteristics were similar between the groups, except that failures had higher 3-h glucose tolerance test (GTT) values at all time points. ROC curves for fasting plasma glucose, pre-pregnancy BMI and BMI at diagnosis revealed no cut-off points for predicting failure of glyburide therapy. However, when fasting plasma glucose value on the GTT was > or = 110 mg/dl, 24% of women failed to respond to glyburide, compared to 12% at < 110 mg/dl (p = 0.15). CONCLUSIONS: In treatment of GDM, glyburide is successful in achieving good glycemic control in most women. Women with high fasting plasma glucose levels, however, may not respond adequately to glyburide therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glyburide, however, has been found to be less likely to maintain satisfactory blood glucose control in women with gestational diabetes who have a fasting blood glucose >110 mg/dL (6.1 mmol/L) on a 100-g OGTT (179) or 50-g glucose challenge (180, 181)”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [179]
In the citing paper
“and is preferred by most patients (179, 183).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [179]
Citations
Cites
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Self-citationChmait, R. H., Dinise, T., Daneshmand, S. S., Kim, M., & Moore, T. R. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(01)80462-2 · Cited by 11
431 Limited efficacy of glyburide for glycemic control
Kitzmiller, J. L. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(01)80463-4 · Cited by 8
Research works printed but not linked: 2
- Gilson G, 2002, Am J Obstet Gynecol, 187, S152
- American Diabetes Association, 2003, Gestational diabetesmellitus . Diabetes Care, 26, S103�5
Cited by
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Endocrine Disorders in Pregnancy
Ramos, G. A., & Moore, T. R. (2012) · Avery's Diseases of the Newborn · doi:10.1016/b978-1-4377-0134-0.10009-5 · Cited by 267
Jacobson, G. F., Ramos, G. A., Ching, J. Y., Kirby, R. S., Ferrara, A., & Field, D. R. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.03.018 · Cited by 177
Metadata
- Authors
- Conway, D. L., Gonzales, O., & Skiver, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- ORCID
- Conway, D. L.
- Venue
- The Journal of Maternal-Fetal & Neonatal Medicine
- Publisher
- Informa UK Limited
- Published
- 2004-01-01
- Volume
- 15
- Issue
- 1
- Pages
- 51-55
- ISSN
- 1476-4954 (ISSN-L)
- 1476-7058
- OpenAlex
- W2020218807
- Cited by
- 112
- References
- 3
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 6 · 2015: 8 · 2014: 6 · 2013: 7 · 2012: 5
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Maternal-Fetal & Neonatal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, glibenclamide, glycemic control, insulin therapy, treatment failure prediction, fasting blood glucose, glucose tolerance test, body mass index, oral antidiabetic drugs
- MeSH terms
- Adult, Blood Glucose, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Glyburide, Humans, Hypoglycemic Agents, Pregnancy, Retrospective Studies, Texas, Randomized Controlled Trials as Topic, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. https://app.cochat.ai/papers/10.1080/14767050310001650725
- The paper
- Conway, D. L., Gonzales, O., & Skiver, D. (2004). Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. The Journal of Maternal-Fetal & Neonatal Medicine. https://doi.org/10.1080/14767050310001650725
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.